DUBLIN, Ireland, July 30, 2019 (GLOBE NEWSWIRE) — Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will …


Link to Full Article: Read Here

Pin It on Pinterest

Share This